Latest News in the pharma Industry
Policy & Regulation
Horizon Pharma Submits NDA for RA Drug
9 Oct 2011
The NDA submission is based on results from a 12 week double-blind placebo-controlled Phase 3 trial involving 350 rheumatoid arthritis patients.
Read more
FDA Approves ANDA of Loxapine Capsules
9 Oct 2011
Lannett Company has received approval from the FDA for its Loxapine Capsules in 5mg, 10mg, 25mg and 50mg doses.
Read more
India's Commerce Ministry Calls for Policy Measures to Boost Pharma Exports to China
8 Oct 2011
A strategic paper by the Indian Commerce Ministry calls for critical policy interventions and special efforts to increase the presence of Indian pharma industry in China.
Read more
AstraZeneca Wins Japanese Approval for Faslodex
30 Sep 2011
AstraZeneca has received regulatory approval for its breast cancer drug Faslodex (fulvestrant) 500mg in Japan.
Read more
Takeda Submits New Drug Application for TAK-085
30 Sep 2011
Takeda has submitted a New Drug Application in Japan for TAK-085 for the treatment of hyperlipidemia.
Read more
HHS Launches New Initiative to Strengthen Primary Care
29 Sep 2011
Under the new initiative, Medicare will work with commercial and state health insurance plans to offer additional support to primary care doctors who better coordinate care for their patients.
Read more
Novartis Receives Japanese Regulatory Approval for Two Innovative Therapies
28 Sep 2011
The Japanese regulators have approved Novartis' once-daily Gilenya (fingolimod) 0.5mg and Illaris (canakinumab) subcutaneous injection 150mg in the Japanese market.
Read more
India Releases Guidelines for Conservation & Development of Medicinal Plants
28 Sep 2011
The scheme released by India's Department of Ayush aims to promote availability of quality plant based raw material.
Read more
Boehringer Ingelheim Receives EU Approval for Viramune Once-daily Formulation
28 Sep 2011
Boehringer Ingelheim has received European approval for its once-daily Viramune tablets for HIV treatment.
Read more
Eisai Receives Canadian Approval of Banzel as Adjunctive Treatment for Severe Epilepsy Disorder
26 Sep 2011
Canadian regulators have given approval of Banzel for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome.
Read more
Tokai Secures Financing to Advance Cancer Drug Study
26 Sep 2011
Tokai Pharmaceuticals has received $23m funding in a Series D3 financing to support its ongoing clinical development of galeterone.
Read more
Remicade Approved to Treat Ulcerative Colitis in Children Older Than 6 Years
26 Sep 2011
Janssen's Remicade has been approved by FDA to treat moderately to severely active ulcerative colitis in children older than 6 years who have had inadequate response to conventional therapy.
Read more